The future of NCI-MATCH looks promising, with ongoing efforts to expand the trial to include more sub-studies and a broader range of genetic targets. As the field of genomics continues to evolve, NCI-MATCH is poised to incorporate new discoveries and technologies, further enhancing its impact on personalized cancer treatment. Ultimately, the trial aims to contribute to a more effective and individualized approach to cancer care, improving outcomes for patients across the globe.
